Viridian Therapeutics, Inc.DE (VRDN) stock
VRDNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30257% above fair value
$30.12+0.06 (+0.20%)
Close on Nov 18, 2026Market cap $3.41BP/E –Yield –
Viridian Therapeutics, Inc.DE enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Viridian Therapeutics, Inc.DE's enterprise value was $2.56B on Nov 11, 2026, against $2.16B a year earlier. Over the last 5 years it ranged from $101.40M to $2.56B, with a median of $585.67M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $2.56B | +22.4% |
| 2025 | Dec 31, 2025 | $2.09B | +166.0% |
| 2024 | Dec 31, 2024 | $785.23M | +22.9% |
| 2023 | Dec 29, 2023 | $638.81M | -14.2% |
| 2022 | Dec 30, 2022 | $744.24M | +339.7% |
| 2021 | Dec 31, 2021 | $169.28M | +362.0% |
| 2020 | Dec 31, 2020 | $36.64M | – |
| 2019 | Dec 31, 2019 | -$13.58M | -142.7% |
| 2018 | Dec 31, 2018 | $31.81M | -83.0% |
| 2017 | Dec 29, 2017 | $186.85M | – |
| 2016 | Dec 30, 2016 | -$20.99M | – |
| 2015 | Dec 31, 2015 | -$4.17M | – |
| 2014 | Dec 31, 2014 | -$5.65M | – |
See a number that looks wrong?